PURPOSE: Limited previous data suggest that heterogeneity exists in the treatment approaches for women with ductal carcinoma in situ (DCIS). We sought in a longitudinal cohort study of women with DCIS to assess the attitudes and management approaches toward DCIS among physicians who provide care to women. MATERIALS AND METHODS: Eligible physicians were invited to participate in a 1-time mailed survey. A financial incentive and reminders were used to enhance the response rate. Physician perception of risks associated with DCIS for patients and management approaches were evaluated. RESULTS: Two hundred and eight physicians were identified, and 151 (73%) completed the survey. Respondents had a median age of 49 years (range, 32-75 years), and most were surgeons or medical oncologists (66%). Eighty-eight percent reported seeing an average of >or= 1 new patient with DCIS per month. In a multivariable model, physicians who cared for proportionately fewer patients with breast cancer were more likely to view DCIS as a riskier disease to a patient's overall health compared with physicians who cared for more women with breast cancer (odds ratio, 2.2; 95% CI, 1.1-4.6; P = .036). Physicians exhibited differences in management approaches when considering theoretical patients with DCIS and did not use consistent terms when speaking with patients with DCIS. CONCLUSION: Substantial variation exists among physicians regarding perceptions and management approaches for women with DCIS. In some settings, risks of physician-recommended therapy might outweigh benefits. Further evaluation of the effects of physician management approaches and attitudes about DCIS on patient outcomes is warranted.
PURPOSE: Limited previous data suggest that heterogeneity exists in the treatment approaches for women with ductal carcinoma in situ (DCIS). We sought in a longitudinal cohort study of women with DCIS to assess the attitudes and management approaches toward DCIS among physicians who provide care to women. MATERIALS AND METHODS: Eligible physicians were invited to participate in a 1-time mailed survey. A financial incentive and reminders were used to enhance the response rate. Physician perception of risks associated with DCIS for patients and management approaches were evaluated. RESULTS: Two hundred and eight physicians were identified, and 151 (73%) completed the survey. Respondents had a median age of 49 years (range, 32-75 years), and most were surgeons or medical oncologists (66%). Eighty-eight percent reported seeing an average of >or= 1 new patient with DCIS per month. In a multivariable model, physicians who cared for proportionately fewer patients with breast cancer were more likely to view DCIS as a riskier disease to a patient's overall health compared with physicians who cared for more women with breast cancer (odds ratio, 2.2; 95% CI, 1.1-4.6; P = .036). Physicians exhibited differences in management approaches when considering theoretical patients with DCIS and did not use consistent terms when speaking with patients with DCIS. CONCLUSION: Substantial variation exists among physicians regarding perceptions and management approaches for women with DCIS. In some settings, risks of physician-recommended therapy might outweigh benefits. Further evaluation of the effects of physician management approaches and attitudes about DCIS on patient outcomes is warranted.
Authors: Ann H Partridge; Joann G Elmore; Debbie Saslow; Worta McCaskill-Stevens; Stuart J Schnitt Journal: CA Cancer J Clin Date: 2012-04-04 Impact factor: 508.702
Authors: Larissa Nekhlyudov; Laurel A Habel; Ninah Achacoso; Inkyung Jung; Reina Haque; Laura C Collins; Stuart J Schnitt; Charles P Quesenberry; Suzanne W Fletcher Journal: J Natl Cancer Inst Date: 2012-04-05 Impact factor: 13.506
Authors: Renée S J M Schmitz; Erica A Wilthagen; Frederieke van Duijnhoven; Marja van Oirsouw; Ellen Verschuur; Thomas Lynch; Rinaa S Punglia; E Shelley Hwang; Jelle Wesseling; Marjanka K Schmidt; Eveline M A Bleiker; Ellen G Engelhardt Journal: Cancers (Basel) Date: 2022-07-02 Impact factor: 6.575
Authors: Shoshana M Rosenberg; Jennifer M Gierisch; Anna C Revette; Carol L Lowenstein; Elizabeth S Frank; Deborah E Collyar; Thomas Lynch; Alastair M Thompson; Ann H Partridge; E Shelley Hwang Journal: Cancer Date: 2022-02-22 Impact factor: 6.921
Authors: Kathryn J Ruddy; Meghan E Meyer; Anita Giobbie-Hurder; Karen M Emmons; Jane C Weeks; Eric P Winer; Ann H Partridge Journal: Oncologist Date: 2013-04-08
Authors: Claire Kim; Frances C Wright; Nicole J Look Hong; Gary Groot; Lucy Helyer; Pamela Meiers; May Lynn Quan; Robin Urquhart; Rebecca Warburton; Anna R Gagliardi Journal: PLoS One Date: 2018-02-05 Impact factor: 3.240
Authors: Virgilio Sacchini; Lucio Fortunato; Hiram S Cody Iii; Kimberly J Van Zee; Bruno Cutuli; Bernardo Bonanni Journal: Int J Surg Oncol Date: 2012-11-06